A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.

Paul W. Sperduto; Meihua Wang; H. Ian Robins; Michael C. Schell; Maria Werner-Wasik; Ritsuko Komaki; Luis Souhami; Mark K. Buyyounouski; Deepak Khuntia; William Demas; Sunjay A. Shah; Lucien A. Nedzi; Gad Perry; John H. Suh; Minesh P. Mehta

doi:10.1016/j.ijrobp.2012.11.042

A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.

Paul W. Sperduto, Meihua Wang, H. Ian Robins, Michael C. Schell, Maria Werner-Wasik, Ritsuko Komaki, Luis Souhami, Mark K. Buyyounouski, Deepak Khuntia, William Demas, Sunjay A. Shah, Lucien A. Nedzi, Gad Perry, John H. Suh, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology Biology Physics
Volume	85
DOIs	https://doi.org/10.1016/j.ijrobp.2012.11.042
State	Published - Jan 4 2013

Disciplines

Medicine and Health Sciences
Medical Biophysics

Access to Document

10.1016/j.ijrobp.2012.11.042License: Unspecified

Cite this

Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., Shah, S. A., Nedzi, L. A., Perry, G., Suh, J. H., & Mehta, M. P. (2013). A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320. International Journal of Radiation Oncology Biology Physics, 85. https://doi.org/10.1016/j.ijrobp.2012.11.042

A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320. / Sperduto, Paul W.; Wang, Meihua; Robins, H. Ian et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 85, 04.01.2013.

Research output: Contribution to journal › Article › peer-review

Sperduto, PW, Wang, M, Robins, HI, Schell, MC, Werner-Wasik, M, Komaki, R, Souhami, L, Buyyounouski, MK, Khuntia, D, Demas, W, Shah, SA, Nedzi, LA, Perry, G, Suh, JH & Mehta, MP 2013, 'A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.', International Journal of Radiation Oncology Biology Physics, vol. 85. https://doi.org/10.1016/j.ijrobp.2012.11.042

Sperduto PW, Wang M, Robins HI, Schell MC, Werner-Wasik M, Komaki R et al. A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320. International Journal of Radiation Oncology Biology Physics. 2013 Jan 4;85. doi: 10.1016/j.ijrobp.2012.11.042

Sperduto, Paul W. ; Wang, Meihua ; Robins, H. Ian et al. / A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320. In: International Journal of Radiation Oncology Biology Physics. 2013 ; Vol. 85.

@article{6f02fe10142b4524a4e8a4a2a221f6df,

title = "A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.",

author = "Sperduto, \{Paul W.\} and Meihua Wang and Robins, \{H. Ian\} and Schell, \{Michael C.\} and Maria Werner-Wasik and Ritsuko Komaki and Luis Souhami and Buyyounouski, \{Mark K.\} and Deepak Khuntia and William Demas and Shah, \{Sunjay A.\} and Nedzi, \{Lucien A.\} and Gad Perry and Suh, \{John H.\} and Mehta, \{Minesh P.\}",

note = "A phase 3 Radiation Therapy Oncology Group (RTOG) study subset analysis demonstrated improved overall survival (OS) with the addition of stereotactic radiosurgery (SRS) to whole brain radiation therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with 1 to 3 brain metastases.",

year = "2013",

month = jan,

day = "4",

doi = "10.1016/j.ijrobp.2012.11.042",

language = "American English",

volume = "85",

journal = "International Journal of Radiation Oncology Biology Physics",

}

TY - JOUR

T1 - A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.

AU - Sperduto, Paul W.

AU - Wang, Meihua

AU - Robins, H. Ian

AU - Schell, Michael C.

AU - Werner-Wasik, Maria

AU - Komaki, Ritsuko

AU - Souhami, Luis

AU - Buyyounouski, Mark K.

AU - Khuntia, Deepak

AU - Demas, William

AU - Shah, Sunjay A.

AU - Nedzi, Lucien A.

AU - Perry, Gad

AU - Suh, John H.

AU - Mehta, Minesh P.

N1 - A phase 3 Radiation Therapy Oncology Group (RTOG) study subset analysis demonstrated improved overall survival (OS) with the addition of stereotactic radiosurgery (SRS) to whole brain radiation therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with 1 to 3 brain metastases.

PY - 2013/1/4

Y1 - 2013/1/4

UR - http://www.sciencedirect.com/science/article/pii/S0360301612038552

U2 - 10.1016/j.ijrobp.2012.11.042

DO - 10.1016/j.ijrobp.2012.11.042

M3 - Article

VL - 85

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

ER -

A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.

Disciplines

Access to Document

Other files and links

Cite this